With a five-year survival rate of less than 5%, glioblastoma is one of the most aggressive types of brain cancer. Read more
Medical News - Nov 20
New Positive Preclinical Data Shows Succesful Drug Distribution to Liver, Peritoneum, and Lung with Measurable Reductions in Tumor Burden at Clinically Relevant Doses Read more
Globenewswire_fr - Sep 11
C$0.78 Million Private Placement Successfully Closed C$0.78 Million Private Placement Successfully Closed Read more
Globe Newswire - Aug 20
On Tuesday, Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) reported second-quarter adjusted earnings of $1.44, up 50% year over year, beating the consensus of 85 cents and sales of $825.41 million, up 16%, beating the consensus of $760.39 million.The sales increase was driven by strong 20% year-over-... Read more
Benzinga - Aug 05